CAMBRIDGE, Mass., April 26, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced today that it will participate in the Deutsche Bank Securities 36th Annual Healthcare Conference. Marc Beer, CEO of Aegerion, is scheduled to present on Monday, May 2, 2011, at 3:30 p.m. ET.
